If we plan an experiment to study the beta-tubulin of an organism w.r.t. its capacity to interact with tubulin binding drugs like Taxol, most studies have used the tubulin purified from some kind of biological source and not the heterologously expressed recombinant beta-tubulin of the target organism. Is it related to the difficulties in expressing the beta-tubulin a properly folded form, its expression or some other reason?